Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV (Metastatic) Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01129336
What this trial is testing

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Who this might be right for
First or Second Line HER2-negative Breast CancerMetastatic Disease Without Bone Metastasis
Novartis Pharmaceuticals 44
Early research (Phase 1)Study completedNCT00199212
What this trial is testing

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

Who this might be right for
Carcinoma Breast Stage IV
Jules Bordet Institute 19
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Large-scale testing (Phase 3)Study completedNCT00004230
What this trial is testing

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

Who this might be right for
Cancer
Northwestern University 35
Testing effectiveness (Phase 2)Study completedNCT00468715
What this trial is testing

Bicalutamide in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)WithdrawnNCT03634150
What this trial is testing

Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer

Who this might be right for
Metastatic Ovarian CancerTriple Negative Breast Cancer
Immune System Key Ltd
Not applicableEnded earlyNCT00949052
What this trial is testing

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 1,000
Not applicableLooking for participantsNCT07635147
What this trial is testing

Decision Support Tool for Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer MetastaticAdvanced Breast CancerStage 4 Breast Cancer+1 more
Weill Medical College of Cornell University 100
Early research (Phase 1)Study completedNCT00055926
What this trial is testing

CP-724,714 in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Jonsson Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT01307891
What this trial is testing

Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast CancerStage IV Breast Cancer+1 more
University of Alabama at Birmingham 64
Large-scale testing (Phase 3)Ended earlyNCT00004935
What this trial is testing

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Who this might be right for
Breast Cancer
Swiss Cancer Institute 175
Early research (Phase 1)UnknownNCT00003920
What this trial is testing

Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of California, Davis 18
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT00237627
What this trial is testing

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+3 more
UNC Lineberger Comprehensive Cancer Center 107
Large-scale testing (Phase 3)Study completedNCT00028990
What this trial is testing

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 722
Testing effectiveness (Phase 2)Study completedNCT01276041
What this trial is testing

Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 70
Early research (Phase 1)WithdrawnNCT05093387
What this trial is testing

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Breast Inflammatory CarcinomaMetastatic Triple-Negative Breast Carcinoma+1 more
Northwestern University
Early research (Phase 1)Study completedNCT00424164
What this trial is testing

Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 20
Testing effectiveness (Phase 2)Study completedNCT00004906
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hackensack Meridian Health
Next Page